Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia

BACKGROUND: The two major obstacles in the successful transplantation of islets for diabetes treatment are inadequate supply of insulin-producing tissue and immune rejection. Induction of the differentiation of human bone marrow-derived mesenchymal stem cells (hMSCs) into insulin-producing cells (IP...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Ying, Jiang, Xin, Wang, Yishu, Su, Xuejin, Sun, Meiyu, Zhang, Lihong, Tan, Yi, Wintergerst, Kupper A., Li, Yan, Li, Yulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710504/
https://www.ncbi.nlm.nih.gov/pubmed/26756576
http://dx.doi.org/10.1371/journal.pone.0145838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710504/
https://www.ncbi.nlm.nih.gov/pubmed/26756576
http://dx.doi.org/10.1371/journal.pone.0145838

Ejemplares similares